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Laparoscopic operations in gynecology performed
globally include benign hysterectomy, myomec-
tomy, adnexal surgery, and staging operations with
lymph node dissections for early gynecologic
cancer. Around 20 years ago, Harry Reich demon-
strated the first case of a laparoscopically assisted
vaginal hysterectomy (LAVH).1 At present, with
the dramatic advances in equipment and skills,
we have the option of total laparoscopic hysterec-
tomy. In gynecological surgery, uterine fibroids
are the most common cause of benign uterine
tumors.2 The traditional primary treatment for
symptomatic myomas is hysterectomy or my-
omectomy. Laparoscopic myomectomy (LM) is
an alternative and advanced technique that can
also take the place of traditional open surgery.
However, LM becomes time-consuming and dif-
ficult in cases where extra-large symptomatic 
myomas are present. Moreover, the risk of intra-
operative hemorrhage and conversion to laparo-
tomy has greatly increased.3 Recently, we have
used the novel surgical technique, in situ morcel-
lation (ISM), while the myoma is attached to the
uterus4 after hemorrhage control with subcap-
sular injection of vasopressin,5 and/or bilateral
ligation of the uterine artery.6,7 We have demon-
strated that the ISM technique can easily and 
efficiently resolve the issue of treating extra-large
myomas, including those greater than 10 cm in
mean diameter. Because LM with concurrent block
of uterine arteries is a novel technique in the
treatment of uterine myomas, the impact of this
technique on the blood flow profile of the uterus
during the postoperative period has been stud-
ied.8,9 Using a prospective three-dimensional (3D)
power Doppler ultrasound study, we can illustrate
that concurrent uterine artery ligation during LM
causes no additional decrease of myometrial per-
fusion.8 The healing of uterine scars after LM has
also been evaluated by 3D power Doppler ultra-
sound. The adequate perfusion demonstrated 
by 3D power Doppler ultrasound encourages
both good uterine scar healing and dissolving of
hematomas.9
This technique will bring many benefits to
new and substitutive surgical techniques. In view
of the relatively shorter operative time and de-
creased blood loss, we would like to clarify that
transvaginal hysterectomy is better for dealing with
uteri weighing less than 350 g, whereas LAVH is
preferable for those weighing 350 g or more.10
However, the increased operative time associated
with LAVH cannot be ignored, especially with
large uteri.6,11,12 For the most part, LAVH for large
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uteri of more than 750 g (as large as gestation at
24th week) are associated with significantly longer
operative time (> 3 hours) than LAVH for uteri
weighing 350–749 g.11 ISM in LAVH now provides
some solutions to the problems associated with
operating on larger uteri. With advancing tech-
niques and an experienced surgical team, LAVH
with ISM can be an efficient and safe procedure
for the removal of large uteri without conversion
to traditional open surgery.13
Because of recent advances in laparoscopic 
techniques and instruments, it is now possible 
to perform all the International Federation of
Gynecologists and Obstetricians guideline stan-
dard surgical staging procedures for early-stage
gynecologic cancer laparoscopically.14−17 However, 
laparoscopy technically hampers the removal of
a large cancer mass, and laparoscopic cancer sur-
gery has a potential risk of trocar site metastasis.
Laparoscopy is suggested to be selectively adopted
for the management of apparently early-stage
disease. At this stage the disease is defined as
organ-confined cancer with no evidence of gross
metastasis based upon preoperative imaging stud-
ies or on laparoscopic inspection.17 There should
be no attempt to utilize laparoscopy for tumor
debulking and cytoreductive surgery.17
Technical advancements make expansions pos-
sible to modern-day laparoscopy and minimally
invasive surgery. These include high-intensity light
sources, improved hand instrumentation, and 
electrosurgical devices. Moreover, robotic telep-
resence technology has been incorporated into the
gynecologic armamentarium after initially being
created for cardiac surgery.18 Robotic surgery of-
fers several advantages over laparoscopy, includ-
ing a 3D vision system, wristed instrumentation,
and ergonomic positioning for the surgeon when
performing surgical procedures.19 The main dis-
advantages of robotic surgery are the cost, the
large size of the robot and console, limited avail-
ability within some health systems, lack of tactile
feedback or haptics, and the need to train resi-
dents, attending surgeons and operating room
personnel on the use of this technology.19 In the
future, well-designed, prospective studies with
well-defined long-term clinical outcomes are 
needed to fully assess the value of this new 
technology.
Disclaimer
Laparoscopic gynecologic surgery has now ad-
vanced to the point of having generally superior
clinical outcomes to traditional open surgery,
with earlier patient recovery and shorter hospital
stay. Laparoscopic gynecologic surgery will likely
continue to develop as more gynecologic surgeons
are trained and more patients seek minimally 
invasive surgical options. Hopefully, we can see
additional improvements as the technology con-
tinues to develop and further refinements occur.
References
1. Reich H, Decaprio J, McGlynn F. Laparoscopic hysterec-
tomy. J Gynecol Surg 1989;5:213–6.
2. Lethaby A, Vollenhoven B. Fibroids (uterine myomatosis,
leiomyomas). Clin Evid 2003:2028–43.
3. Dubuisson JB, Fauconnier A, Fourchotte V, et al. Laparo-
scopic myomectomy: predicting the risk of conversion to
an open procedure. Hum Reprod 2001;16:1726–31.
4. Torng PL, Hwang JS, Huang SC, et al. Effect of simultane-
ous morcellation in situ on operative time during laparo-
scopic myomectomy. Hum Reprod 2008;23:2220–6.
5. Shimanuki H, Takeuchi H, Kitade M, et al. The effect of
vasopressin on local and general circulation during laparo-
scopic surgery. J Minim Invasive Gynecol 2006;13:190–4.
6. Chang WC, Torng PL, Huang SC, et al. Laparoscopic-
assisted vaginal hysterectomy with uterine artery ligation
through retrograde umbilical ligament tracking. J Minim
Invasive Gynecol 2005;12:336–42.
7. Hsu WC, Chang WC, Huang SC, et al. Laparoscopic-
assisted vaginal hysterectomy for patients with extensive
pelvic adhesions: a strategy to minimize conversion to 
laparotomy. Aust N Z J Obstet Gynaecol 2007;47:230–4.
8. Chang WC, Huang SC, Sheu BC, et al. Changes in 
uterine blood flow following laparoscopic myomectomy
with or without uterine artery ligation on two- and three-
dimensional power Doppler ultrasound. Ultrasound
Obstet Gynecol 2009;33:221–7.
9. Chang WC, Chang DY, Huang SC, et al. Use of three-
dimensional ultrasonography in the evaluation of uterine
perfusion and healing after laparoscopic myomectomy.
Fertil Steril 2009;92:1110–5.
Advances in gynecological laparoscopic surgery
J Formos Med Assoc | 2010 • Vol 109 • No 4 247
10. Chang WC, Huang SC, Sheu BC, et al. Transvaginal hysterec-
tomy or laparoscopically assisted vaginal hysterectomy for
nonprolapsed uteri. Obstet Gynecol 2005;106:321–6.
11. Chang WC, Huang SC, Sheu BC, et al. LAVH for large uteri
by various strategies. Acta Obstet Gynecol Scand 2008;
87:558–63.
12. Hsu WC, Hwang JS, Chang WC, et al. Prediction of oper-
ation time for laparoscopic myomectomy by ultrasound
measurements. Surg Endosc 2007;21:1600–6.
13. Chen SY, Chang DY, Sheu BC, et al. Laparoscopic-assisted
vaginal hysterectomy with in situ morcellation for large
uteri. J Minim Invasive Gynecol 2008;15:559–65.
14. Park JY, Kim DY, Suh DS, et al. Comparison of laparoscopy
and laparotomy in surgical staging of early-stage ovarian and
fallopian tubal cancer. Ann Surg Oncol 2008;15:2012–9.
15. Renaud MC, Plante M, Roy M. Combined laparoscopic and
vaginal radical surgery in cervical cancer. Gynecol Oncol
2000;79:59–63.
16. Palomba S, Falbo A, Mocciaro R, et al. Laparoscopic treat-
ment for endometrial cancer: a meta-analysis of random-
ized controlled trials (RCTs). Gynecol Oncol 2009;112:
415–21.
17. Ghezzi F, Cromi A, Uccella S, et al. Incorporating laparo-
scopy in the practice of a gynecologic oncology service: 
actual impact beyond clinical trials data. Ann Surg Oncol
2009;16:2305–14.
18. Diodato MD Jr, Damiano RJ Jr. Robotic cardiac surgery:
overview. Surg Clin North Am 2003;83:1351–67, ix.
19. Visco AG, Advincula AP. Robotic gynecologic surgery.
Obstet Gynecol 2008;112:1369–84.
